Defined peptide fragment
TB-500 is described in scientific literature as a synthetic, N-acetylated variant of the LKKTETQ fragment associated with thymosin beta-4. Its short, defined structure supports reliable analytical identification.
Analytical identification
The nominal content of 10 mg provides a traceable reference point for peptide profiles, chromatographic methods and mass-spectrometric comparison within a controlled laboratory setting.
Scientific mechanism
TB-500 is generally referred to as the N-acetylated heptapeptide Ac-LKKTETQ, a sequence associated with thymosin beta-4. Its scientific context is therefore primarily structural and analytical: sequence identity, acetylation and comparison with thymosin beta-4 fragments.
Batch documentation
Before each study, always check the product label, selected presentation and batch number. Compare these details, where available, with the batch documentation and lab results.
Important research-use notice
This item is intended exclusively for controlled analytical and in-vitro laboratory research. It is not intended for human or animal consumption, use, administration, diagnosis, prevention or treatment. VLT Labs does not provide dosage, medical, health or application advice.
